Symphony Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/5ro6y0jwj1s2fr217ii28f63.pdf

Key Takeaways


Domestic Demand & Channel Dynamics

Bakeri: "We cannot expect, this kind of growth, though we will be very happy if, this kind of growth continues. But that's very unlikely to happen. So, I think we shouldn't expect that going forward."

Overseas Subsidiaries: The Tale of Four Markets

SubsidiaryTrendCommentary
Bonaire USA▲ Strong growthRevenue up 35% on successful scale-up of new "Air Force" air-cooler model sold to Home Depot and Lowe's, aided by a very good summer in the US Southwest; revenue will continue into Q2 but then go muted in Q3 and Q4 as coolers are seasonal.
GSK China▲ Strong growthRevenue up 43% with operating leverage lifting profitability; now completely debt-free on a standalone basis after repaying all debt plus interest to Symphony India; more even sales cycle due to industrial coolers and exports.
IMPCO Mexico▼ WeakTwo consecutive mild summers (2025 and 2026) suppressed sales, a pattern people with 30+ years at the company have never seen; management views a third mild summer as statistically almost impossible, so summer of '27 should be robust.
CTPL Australia▼ Continued softeningEBITDA negative ₹4 crore; PAT inflated by a one-time ₹42 crore gain on sale of Bonaire USA shareholding and IPRs that nets off at the consolidated level; strategy is "just more of the same, nothing new" with no additional capital deployed.
Shah: "First and foremost, our strategy is not to deploy any additional capital and whatever best can be done without deploying any additional capital in our Australian business. The point is that we are very clear internally and also to assure all the shareholders that whatever impairment or write-off is the history that's not going to happen."

Margins & Cost Pressures

Bakeri: "So, in the short term, margins are likely to be impacted. ... Despite all the value engineering, despite all the cost reduction that we will be attempting to do, there will be some impact. Difficult to quantify as yet how much, but there is likely to be some impact."

Capital Allocation & Balance Sheet


Product & Channel Expansion


Guidance & Commitments

CommitmentSpecificsTimeline
No further capital to AustraliaZero additional capital deployment; strategy is to optimize without fresh investmentOngoing
General trade growth resumptionGeneral trade and all other trade channels expected to register growth now that inventory is normalizedIn line with business plan
Household cooler price hikesHikes to be taken; extent depends on cost normalization"In the days to come"
Mexico recoverySummer of '27 statistically almost impossible to be mild; sales should grow significantlySummer of '27
BISP GT expansionTabletop fans and water heaters to be present everywhere in GT across the country"Just a matter of time"
Near-term margin impactSome margin compression likely; difficult to quantifyShort term

Key Metrics

MetricQ1 FY27
Consolidated revenue₹378 cr, up 8% YoY
Consolidated EBITDA₹48 cr, up 26% YoY from ₹38 cr
Consolidated EBITDA (adjusted)₹53 cr, vs ₹38 cr in Q1 FY26, excluding one-time non-cash expenditure of ₹5 cr
Consolidated PAT₹40 cr, down from ₹42 cr
Consolidated PAT (adjusted)₹43 cr, up 23% YoY from ₹35 cr, excluding one-offs
Consolidated gross margin49.8%, marginally increased YoY
Consolidated EBITDA margin12.6%
Standalone revenue₹241 cr, vs ₹229 cr
Standalone EBITDA₹30 cr, vs ₹24 cr
Standalone PAT₹28 cr, vs ₹37 cr; adjusted ₹28 cr vs ₹24 cr excluding one-offs in both quarters
Domestic (India) revenue growth15% YoY
Modern trade growthin excess of 100% YoY
BISP share of consolidated TTM revenue~48%, ~₹560 cr
BISP share of standalone TTM revenue23%, ₹179 cr
Standalone ROCE164%
Standalone return on net worth22%
Consolidated ROCE67%
Consolidated return on net worth18%
Standalone treasury₹345 cr, vs ₹363 cr as of 30 June '26
Consolidated capital employed₹206 cr, vs ₹409 cr as of 30 June '26
Standalone core capital employed₹73 cr, vs ₹136 cr as of 30 June '26
Bonaire USA revenue₹36 cr, up 35% YoY from ₹27 cr
Bonaire USA EBITDA₹18 cr, vs ₹7 cr; PAT ₹17 cr
GSK China revenue₹34 cr, up 43% YoY from ₹24 cr
GSK China EBITDA₹6 cr, vs ₹2 cr; PAT ₹5 cr
IMPCO Mexico revenue₹54 cr, vs ₹66 cr
IMPCO Mexico EBITDA₹3 cr, vs ₹7 cr; PAT ₹1 cr
CTPL Australia revenue₹27 cr, vs ₹31 cr
CTPL Australia EBITDAnegative ₹4 cr, vs negative ₹2 cr
Interim dividend₹1 per share, total payout ~₹7 cr
Price hike (ex-household cooler segment)7% to 10%